Natural Investments LLC Invests $249,000 in Aflac Incorporated (NYSE:AFL)

Natural Investments LLC acquired a new position in Aflac Incorporated (NYSE:AFL) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,410 shares of the financial services provider’s stock, valued at approximately $249,000.

Several other large investors have also recently bought and sold shares of the business. Private Trust Co. NA raised its position in Aflac by 1.3% in the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares in the last quarter. Phillips Wealth Planners LLC raised its position in Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. raised its position in Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after acquiring an additional 100 shares in the last quarter. TKG Advisors LLC raised its position in Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after acquiring an additional 103 shares in the last quarter. Finally, Covestor Ltd raised its position in Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Down 1.5 %

AFL opened at $104.67 on Thursday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a market cap of $57.21 billion, a P/E ratio of 10.90, a PEG ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The business’s fifty day simple moving average is $105.24 and its 200 day simple moving average is $107.70.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now directly owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 55,546 shares of company stock valued at $5,863,616 over the last quarter. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

AFL has been the subject of several research analyst reports. Wells Fargo & Company cut their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Evercore ISI dropped their price target on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Keefe, Bruyette & Woods dropped their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. raised their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.